Wednesday, July 8, 2026

pharma · Epilepsy · Allergic Reaction · AQST

Aquestive Therapeutics

Aquestive Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, CA
Founded
2009
Employees
75
Programs
9
Drugs
9
Patents
17
Intelligence · Clinical Trials

Aquestive Therapeutics clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Aquestive Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Aquestive Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Aquestive Therapeutics.

  1. 42-1703 — Phase 3

    Clinical update
  2. Riluzole Oral Soluble Film — Phase 2

    Clinical update
  3. Ondansetron (ODFS) — Phase 2

    Clinical update
  4. Diazepam Buccal Film — Phase 2

    Clinical update
  5. Diazepam Buccal Film 12.5 mg — Phase 2

    Clinical update
  6. DESF — Phase 2

    Clinical update
  7. Riluzole Oral Soluble film (ROSF) 50 mg — Phase 2

    Clinical update
  8. Ondansetron (ODFS) — Phase 1

    Clinical update

Trial registry

10 studies